Adult lymphoblastic lymphoma: High incidence of central nervous system relapse in patients treated with the stanford university protocol

J. W. Sweetenham, G. M. Mead, J. M.A. Whitehouse

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Twelve adult patients with non-leukaemic lymphoblastic lymphoma were treated with combination chemotherapy and central nervous system prophylaxis according to the protocol developed at Stanford University. Despite strict adherence to the Stanford protocol, 4 of 12 patients relapsed in the CNS, all with meningeal disease. Only four of the 12 patients are in continuing complete remission 6 to 88 months from the completion of induction therapy. These results are inferior to those previously reported for this regimen, and fail to confirm the high rate of control of CNS disease.

Original languageEnglish (US)
Pages (from-to)839-841
Number of pages3
JournalAnnals of Oncology
Volume3
Issue number10
StatePublished - Dec 1 1992
Externally publishedYes

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Central Nervous System
Recurrence
Incidence
Central Nervous System Diseases
Combination Drug Therapy
Stanford University protocol
Therapeutics

Keywords

  • Chemotherapy
  • CNS
  • Lymphoblastic lymphoma
  • Relapse

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Adult lymphoblastic lymphoma : High incidence of central nervous system relapse in patients treated with the stanford university protocol. / Sweetenham, J. W.; Mead, G. M.; Whitehouse, J. M.A.

In: Annals of Oncology, Vol. 3, No. 10, 01.12.1992, p. 839-841.

Research output: Contribution to journalArticle

@article{e9740ea0498544a78bc1adbfd0fe014c,
title = "Adult lymphoblastic lymphoma: High incidence of central nervous system relapse in patients treated with the stanford university protocol",
abstract = "Twelve adult patients with non-leukaemic lymphoblastic lymphoma were treated with combination chemotherapy and central nervous system prophylaxis according to the protocol developed at Stanford University. Despite strict adherence to the Stanford protocol, 4 of 12 patients relapsed in the CNS, all with meningeal disease. Only four of the 12 patients are in continuing complete remission 6 to 88 months from the completion of induction therapy. These results are inferior to those previously reported for this regimen, and fail to confirm the high rate of control of CNS disease.",
keywords = "Chemotherapy, CNS, Lymphoblastic lymphoma, Relapse",
author = "Sweetenham, {J. W.} and Mead, {G. M.} and Whitehouse, {J. M.A.}",
year = "1992",
month = "12",
day = "1",
language = "English (US)",
volume = "3",
pages = "839--841",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Adult lymphoblastic lymphoma

T2 - High incidence of central nervous system relapse in patients treated with the stanford university protocol

AU - Sweetenham, J. W.

AU - Mead, G. M.

AU - Whitehouse, J. M.A.

PY - 1992/12/1

Y1 - 1992/12/1

N2 - Twelve adult patients with non-leukaemic lymphoblastic lymphoma were treated with combination chemotherapy and central nervous system prophylaxis according to the protocol developed at Stanford University. Despite strict adherence to the Stanford protocol, 4 of 12 patients relapsed in the CNS, all with meningeal disease. Only four of the 12 patients are in continuing complete remission 6 to 88 months from the completion of induction therapy. These results are inferior to those previously reported for this regimen, and fail to confirm the high rate of control of CNS disease.

AB - Twelve adult patients with non-leukaemic lymphoblastic lymphoma were treated with combination chemotherapy and central nervous system prophylaxis according to the protocol developed at Stanford University. Despite strict adherence to the Stanford protocol, 4 of 12 patients relapsed in the CNS, all with meningeal disease. Only four of the 12 patients are in continuing complete remission 6 to 88 months from the completion of induction therapy. These results are inferior to those previously reported for this regimen, and fail to confirm the high rate of control of CNS disease.

KW - Chemotherapy

KW - CNS

KW - Lymphoblastic lymphoma

KW - Relapse

UR - http://www.scopus.com/inward/record.url?scp=0026678041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026678041&partnerID=8YFLogxK

M3 - Article

C2 - 1286046

AN - SCOPUS:0026678041

VL - 3

SP - 839

EP - 841

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 10

ER -